Exactus, Inc. (EXDI) Research

Exactus, Inc. is a leading producer and supplier, specializing in ingredients derived from hemp as well as cutting-edge feminized hemp genetics. The company's offerings include feminized genetic strains rich in both cannabidiol (CBD) and high-cannabigerol (CBG). Beyond genetics, Exactus provides a comprehensive range of hemp-derived specialty ingredients, such as purified isolates of CBD, CBG, CBN, and CBC; potent CBD and CBG distillates; water-soluble CBD formulations; raw CBD and CBG biomass; dried CBD and CBG flowers; and CBD crude oil. They also offer white-label product solutions, serving a diverse clientele across the cosmetic, health and wellness, food and beverage, pharmaceutical, and pet care sectors. Exactus further extends its capabilities to custom manufacturing an assortment of cannabinoid-infused specialty products, including skincare items, pain relief creams, tinctures, bath bombs, soft gels, balms, pet-specific goods, and dietary supplements. The company's operations are based in Delray Beach, Florida, functioning as a subsidiary under Ceed2Med, LLC.

Open Exactus, Inc. (EXDI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.